Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Link opens in a new tab
Search content at University of Birmingham
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Anti-angiogenesis in cancer therapy: Hercules and hydra
S. Bellou
, G. Pentheroudakis
, C. Murphy
, T. Fotsis
Biosciences
Research output
:
Contribution to journal
›
Article
›
peer-review
70
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anti-angiogenesis in cancer therapy: Hercules and hydra'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
In Cancer
100%
Hydra
100%
Cancer Therapy
100%
Anti-angiogenesis
100%
Hercules
100%
Antiangiogenic Agents
100%
Clinical Outcomes
33%
Mini
33%
Tumor
33%
Vascular Endothelial Growth Factor
33%
Solid Tumors
33%
Chemotherapy
33%
Signaling Cascades
33%
Growth Factors
33%
Metastasis
33%
Overall Survival
33%
Angiogenesis
33%
Molecular Mechanism
33%
Anticancer Treatment
33%
Resistance Development
33%
Antiangiogenic Therapy
33%
Antiangiogenic
33%
Humanized Antibody
33%
Accumulated Experience
33%
Initial Expectations
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Angiogenesis Inhibitor
100%
Vasculotropin
66%
Neoplasm
33%
Solid Malignant Neoplasm
33%
Growth Factor
33%
Overall Survival
33%
Chemotherapy
33%
Antiangiogenic Therapy
33%
Antiangiogenic
33%
Vasculotropin A
33%